bumetanide has been researched along with Hyperuricemia in 2 studies
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, CS | 1 |
| Shen, W | 1 |
| Boulton, DW | 1 |
| Leslie, BR | 1 |
| Griffen, SC | 1 |
| Jutabha, P | 1 |
| Anzai, N | 1 |
| Kitamura, K | 1 |
| Taniguchi, A | 1 |
| Kaneko, S | 1 |
| Yan, K | 1 |
| Yamada, H | 1 |
| Shimada, H | 1 |
| Kimura, T | 1 |
| Katada, T | 1 |
| Fukutomi, T | 1 |
| Tomita, K | 1 |
| Urano, W | 1 |
| Yamanaka, H | 1 |
| Seki, G | 1 |
| Fujita, T | 1 |
| Moriyama, Y | 1 |
| Yamada, A | 1 |
| Uchida, S | 1 |
| Wempe, MF | 1 |
| Endou, H | 1 |
| Sakurai, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-Label, Parallel-group, Multiple-Dose Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects[NCT00930865] | Phase 1 | 42 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bumetanide and Hyperuricemia
| Article | Year |
|---|---|
Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.
Topics: Adolescent; Adult; Benzhydryl Compounds; Bumetanide; Drug Interactions; Female; Glucosides; Healthy | 2018 |
1 other study available for bumetanide and Hyperuricemia
| Article | Year |
|---|---|
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Topics: Animals; Bumetanide; Diuretics; Furosemide; Genetic Predisposition to Disease; Glucose Transport Pro | 2010 |